Synapse
⌘+K
Synapse
PulseExploreClubsResearchersJournals
Instagram
HomeClubsExplore
March 28, 2024Open Access

Identifying Potential Drug Targets for the Treatment of Ulcerative Colitis Using Mendelian Randomization Combined with Co-localization Analysis

View Full Paper
Ask AI
Bookmark
Share

Authors

TZTianyu Zhang

Discussion

Loading...

Member takes

Overview

Key Points

Key points are not available for this paper at this time.

Cite This Study

Tianyu Zhang (2024) studied this question.

synapsesocial.com/papers/68e71fddb6db643587699561https://doi.org/10.21203/rs.3.rs-4157703/v1
View Full Paper
Ask AI
Bookmark
Share

Also Consider

Synapse has enriched 5 closely related papers on similar clinical questions. Consider them for comparative context:

  1. 1Exploring inflammatory bowel disease therapy targets through druggability genes: a Mendelian randomization study2024 · 1 citations
  2. 2Multi-omics mendelian randomization integrating GWAS and eQTL data revealed potential drug target for irritable bowel syndrome2026
  3. 3Multi-omics integration analysis based on plasma circulating proteins reveals potential therapeutic targets for ulcerative colitis2025
  4. 4Cell-type specific analyses in blood and gut identify cis-eQTL matching 140 IBD risk loci and entrectinib as repurposing candidate2026
  5. 5Systematic Identification and Characterization of Causal Risk GenesImplicated in Colorectal Cancer by Integrating GWAS, eQTL, and mQTLData2026